NASDAQ: MRVI Q1 2024 Financial Results May 8, 2024 Agenda 01 Welcome Deb Hart, Head of Investor Relations 02 Business Highlights Trey Martin, Chief Executive Officer 03 Financial Results Kevin Herde, Chief Financial Officer & Guidance 04 Q&A Session Trey Martin, Chief Executive Officer Kevin Herde, Chief Financial Officer Drew Burch, President, Nucleic Acid Production Becky Buzzeo, Chief Commercial Officer 2 © 2024 MaravaiLifeSciences Forward Looking Statements and Use of Non-GAAP Financial Measures This pr ...